The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients
- 30 September 1993
- journal article
- Published by Elsevier in Metabolism
- Vol. 42 (9), 1217-1222
- https://doi.org/10.1016/0026-0495(93)90284-u
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Quantitation of Muscle Glycogen Synthesis in Normal Subjects and Subjects with Non-Insulin-Dependent Diabetes by13C Nuclear Magnetic Resonance SpectroscopyNew England Journal of Medicine, 1990
- Effect of Metformin on Carbohydrate and Lipoprotein Metabolism in NIDDM PatientsDiabetes Care, 1990
- Postreceptor effects of sulfonylurea on skeletal muscle glycogen synthase activity in type II diabetic patientsDiabetes, 1989
- The Effects of Metformin on Adipocyte Insulin Action and Metabolic Control in Obese Subjects with Type 2 DiabetesDiabetic Medicine, 1989
- Metformin improves peripheral but not hepatic insulin action in obese patients with type II diabetesActa Endocrinologica, 1989
- Metformin Revisited: Its Actions and Indications for UseDiabetic Medicine, 1988
- Radioimmunological determination of human C-peptide in serumDiabetologia, 1975
- Inhibition of gluconeogenesis from lactate by phenylethylbiguanide in the perfused guinea pig liverDiabetologia, 1972
- The hypoglycaemic action of metforminPublished by Oxford University Press (OUP) ,1971
- Specific Inhibition of Gluconeogenesis by BiguanidesNature, 1967